OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

ECT2 Mouse Monoclonal Antibody [Clone ID: OTI2D9]

  • Product Brand Image
Be the first to review this product
SKU
TA807408S
ECT2 mouse monoclonal antibody, clone OTI2D9 (formerly 2D9)
Size:
30 ul 100 ul
Conjugation:
Unconjugated
  $200.00
2 Days*
Bulk/Customize

Frequently Bought Together (2)

TA811000S beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control 30 ul
$200.00
LY413314 Transient overexpression lysate of epithelial cell transforming sequence 2 oncogene (ECT2) (as WB positive control) 100 ug
$436.00

View other "ECT2 or NM_018098" antibodies

Specifications
Specifications
Product Data
Clone Name OTI2D9
Application IHC, WB
Recommended Dilution WB 1:2000, IHC 1:150
Reactivity Human
Antibody Host Mouse
Isotype IgG1
Clonality Monoclonal
Immunogen Human recombinant protein fragment corresponding to amino acids 175-438 of human ECT2(NP_060568) produced in E.coli.
Buffer PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide
Concentration 1 mg/ml
Purification Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
Conjugation Unconjugated
Storage Store at -20°C as received.
Stability Stable for 12 months from date of receipt.
Shipping Blue Ice
Predicted Protein Size 99.9 kDa
Gene Name epithelial cell transforming 2
Database Link
Background The protein encoded by this gene is a guanine nucleotide exchange factor and transforming protein that is related to Rho-specific exchange factors and yeast cell cycle regulators. The expression of this gene is elevated with the onset of DNA synthesis and remains elevated during G2 and M phases. In situ hybridization analysis showed that expression is at a high level in cells undergoing mitosis in regenerating liver. Thus, this protein is expressed in a cell cycle-dependent manner during liver regeneration, and is thought to have an important role in the regulation of cytokinesis. Several transcript variants encoding two different isoforms have been found for this gene. provided by RefSeq, Apr 2012
Synonyms ARHGEF31
Reference Data
Protein Categories Cytokines, Intracellular Proteins
Protein Families Druggable Genome
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources
Other "OTI2D9" antibodies (4)
SKU Description Size Price
CF807408 Carrier-free (BSA/glycerol-free) ECT2 mouse monoclonal antibody, clone OTI2D9 (formerly 2D9) 100 ug
$620.00
TA807408 ECT2 mouse monoclonal antibody, clone OTI2D9 (formerly 2D9) 100 ul
$447.00
TA807408AM ECT2 mouse monoclonal antibody, clone OTI2D9 (formerly 2D9), Biotinylated 100 ul
$509.00
TA807408BM ECT2 mouse monoclonal antibody, clone OTI2D9 (formerly 2D9), HRP conjugated 100 ul
$509.00

file-alt Citations

A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma
Kubota, Yoshida, Kageyama et al
World J Surg Oncol (2020) 18 (1), 270 DOI: 10.1186/s12957-020-02046-9
Cited by 8
AI Summary: OriGene products contributed to this study by providing the specific antibodies used for immunohistochemical analysis of the four biomarkers—ARL4C (Anti-ARL4C antibody, TA322251), ECT2 (Anti-ECT2 antibody, TA323082), SOD2 (Anti-SOD2 antibody, TA802246), and STEAP3 (Anti-STEAP3 antibody, TA322879)—enabling the researchers to assess their expression in renal cell carcinoma tissues and develop the prognostic model.
FigureFigureFigure
A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma
Kubota, Yoshida, Kageyama et al
World J Surg Oncol (2020) 18 (1), 270 DOI: 10.1186/s12957-020-02046-9
Cited by 8
AI Summary: OriGene contributed to this study by providing the ECT2 primary antibody (#CF807408), which was used for immunohistochemical analysis to assess biomarker expression in renal cell carcinoma tissues as part of developing and validating the prognostic risk stratification model.
Snippet: They were then incubated overnight at 4 ℃ with primary antibodies against ARL4C (diluted 1:400, #10202-1-AP, Proteintech, IL), ECT2 (diluted 1:200, #CF807408, Origene, MD), SOD2 (diluted 1:1000, #06-984, Millipore Corporation;- They were then incubated overnight at 4 ℃ with primary antibodies against ARL4C (diluted 1:400, #10202-1-AP, Proteintech, IL), ECT2 (diluted 1:200, #CF807408, Origene, MD), SOD2 (diluted 1:1000, #06-984, Millipore Corporation
IHC
Showing 1-2 of 2 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products